IRIS Accounts Production v24.3.0.553 04133176 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041331762023-03-31041331762024-03-31041331762023-04-012024-03-31041331762022-03-31041331762022-04-012023-03-31041331762023-03-3104133176ns15:EnglandWales2023-04-012024-03-3104133176ns14:PoundSterling2023-04-012024-03-3104133176ns10:Director12023-04-012024-03-3104133176ns10:CompanyLimitedByGuarantee2023-04-012024-03-3104133176ns10:SmallEntities2023-04-012024-03-3104133176ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104133176ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104133176ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104133176ns10:FullAccounts2023-04-012024-03-3104133176ns10:Director22023-04-012024-03-3104133176ns10:Director32023-04-012024-03-3104133176ns10:Director42023-04-012024-03-3104133176ns10:Director52023-04-012024-03-3104133176ns10:Director62023-04-012024-03-3104133176ns10:Director72023-04-012024-03-3104133176ns10:Director82023-04-012024-03-3104133176ns10:Director92023-04-012024-03-3104133176ns10:RegisteredOffice2023-04-012024-03-3104133176ns5:CurrentFinancialInstruments2024-03-3104133176ns5:CurrentFinancialInstruments2023-03-3104133176ns5:RetainedEarningsAccumulatedLosses2024-03-3104133176ns5:RetainedEarningsAccumulatedLosses2023-03-3104133176ns5:PlantMachinery2023-04-012024-03-3104133176ns5:PlantMachinery2023-03-3104133176ns5:ComputerEquipment2023-03-3104133176ns5:PlantMachinery2024-03-3104133176ns5:ComputerEquipment2024-03-3104133176ns5:PlantMachinery2023-03-3104133176ns5:ComputerEquipment2023-03-3104133176ns5:CostValuation2023-03-3104133176ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104133176ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-31
REGISTERED NUMBER: 04133176 (England and Wales)











UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: RH Sammons
MR Bending
M E C Dockrell
Professor B M Hendry
Dr M Phanish
Professor R G Price
S Simper
Dr S L Hyer
Professor D L Baines





REGISTERED OFFICE: The Renal Unit
St Helier Hospital
Wrythe Lane
Carshalton
Surrey
SM5 1AA





REGISTERED NUMBER: 04133176 (England and Wales)





ACCOUNTANTS: GBJ Financial Limited
Sterling House
27 Hatchlands Road
Redhill
Surrey
RH1 6RW

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investments 5 9,510 9,510
9,510 9,510

CURRENT ASSETS
Debtors 6 12,865 4,227
Cash at bank 70,920 86,985
83,785 91,212
CREDITORS
Amounts falling due within one year 7 26,679 27,089
NET CURRENT ASSETS 57,106 64,123
TOTAL ASSETS LESS CURRENT
LIABILITIES

66,616

73,633

RESERVES
Income and expenditure account 66,616 73,633
66,616 73,633

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 December 2024 and were signed on its behalf by:





Dr M Phanish - Director


SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

South West Thames Institute for Renal Research is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises net amounts invoiced in respect of research contracts (excluding value added tax) together with voluntary income from donations and grants received or due in relation to expenses incurred in the year. Any amounts received in advance are carried forward as deferred income to the following year.


Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2023
and 31 March 2024 265,601 17,819 283,420
DEPRECIATION
At 1 April 2023
and 31 March 2024 265,601 17,819 283,420
NET BOOK VALUE
At 31 March 2024 - - -
At 31 March 2023 - - -

SOUTH WEST THAMES INSTITUTE
FOR RENAL RESEARCH (REGISTERED NUMBER: 04133176)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


5. FIXED ASSET INVESTMENTS
Other
investment
£   
COST
At 1 April 2023
and 31 March 2024 9,510
NET BOOK VALUE
At 31 March 2024 9,510
At 31 March 2023 9,510

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors - 2,500
Other debtors 12,865 1,727
12,865 4,227

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 13,786 9,849
Other creditors 12,893 17,240
26,679 27,089

8. LIMITED BY GUARANTEE

South West Thames Institute for Renal Research is a non-profit making company limited by guarantee and has no share capital.